Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Nat Commun ; 15(1): 5191, 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38890283

ABSTRACT

A recent clinical trial demonstrated that Bacille Calmette-Guérin (BCG) revaccination of adolescents reduced the risk of sustained infection with Mycobacterium tuberculosis (M.tb). In a companion phase 1b trial, HVTN 602/Aeras A-042, we characterize in-depth the cellular responses to BCG revaccination or to a H4:IC31 vaccine boost to identify T cell subsets that could be responsible for the protection observed. High-dimensional clustering analysis of cells profiled using a 26-color flow cytometric panel show marked increases in five effector memory CD4+ T cell subpopulations (TEM) after BCG revaccination, two of which are highly polyfunctional. CITE-Seq single-cell analysis shows that the activated subsets include an abundant cluster of Th1 cells with migratory potential. Additionally, a small cluster of Th17 TEM cells induced by BCG revaccination expresses high levels of CD103; these may represent recirculating tissue-resident memory cells that could provide pulmonary immune protection. Together, these results identify unique populations of CD4+ T cells with potential to be immune correlates of protection conferred by BCG revaccination.


Subject(s)
BCG Vaccine , CD4-Positive T-Lymphocytes , Mycobacterium tuberculosis , Mycobacterium tuberculosis/immunology , Humans , Adolescent , CD4-Positive T-Lymphocytes/immunology , BCG Vaccine/immunology , Immunization, Secondary , Tuberculosis/immunology , Tuberculosis/prevention & control , Tuberculosis/microbiology , Female , Male , Phenotype , Single-Cell Analysis , Th1 Cells/immunology , Immunologic Memory/immunology
SELECTION OF CITATIONS
SEARCH DETAIL